Table 1.
Clinical characteristics of participants in PSS and control groups.
| PSS | Control | p value | |
|---|---|---|---|
| Number | 12 | 12 | |
| Gender (male, %) | 5, 41.7 | 4, 33.3 | 0.673Ψ |
| Age (years) | 51.3 ± 9.9 | 58.3 ± 7.9 | 0.072 |
| IOP (mmHg) | 21.6 ± 9.4 | 14.3 ± 2.6 | 0.02* |
| BCVA | 3.64 ± 1.9 | 3.93 ± 0.7 | 0.687 |
| CD | 2704.6 ± 190.9 | 2626.7 ± 282.3 | 0.486 |
| KP (y/n) | 12/0 | 0/12 | <0.001Ψ** |
| Tyndall (y/n) | 3/9 | 0/12 | 0.064Ψ |
| Vertical C/D | 0.4 (0.3–0.9) | 0.3 | <0.001#*** |
PSS, Posner–Schlossman syndrome; BCVA, best-corrected visual acuity; IOP, intraocular pressure; CD, cell density; KP, keratic precipitate; C/D, ratio of cup to disk. # by Mann–Whitney U test; Ψ, by χ2 test. *, p value < 0.05; **, p value < 0.01.